GGrantIndex
Sort

82,697 grants matching vaccine development

Units for HIV/AIDS Clinical Trials Networks

$2,310,776
Ram Yogev · Lurie Children'S Hospital Of Chicago · U01 · FY2007 · AI

Automated, optimized, intelligent data collection for cryo-EM

$2,310,594
Gabriel C Lander · Scripps Research Institute, The · R01 · FY2025 · GM

Immuno-Prophylaxis-Therapy &Diagnosis of Tularemia

$2,310,008
Boston Medical Center · U19 · FY2005 · AI

DELINEATION AND VULNERABILITIES OF HIV-1 ESCAPE FROM NEUTRALIZING ANTIBODIES

$2,310,000
Alon Herschhorn · University Of Minnesota · DP2 · FY2019 · DA

Ebola Vaccine Development

$2,309,604
Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant

$2,309,363
Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2024 · CA

Defining regulators of immunity to acute infection using CRISPR screens

$2,309,197
Arlene H Sharpe · Harvard Medical School · U19 · FY2019 · AI

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

$2,309,154
Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA

Miami Center for AIDS Research

$2,309,083
Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2020 · AI

Novel TLR7/8 agonists as adjuvants for rapid-acting vaccines

$2,308,292
David Johnson · Corixa Corporation · N01 · FY2009 · AI

COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)

$2,307,858
Tom Denny · Duke University · N01 · FY2021 · AI

The intersection of innate and adaptive immunity to intracellular pathogens

$2,307,757
Daniel A Portnoy · University Of California Berkeley · P01 · FY2021 · AI

City of Hope Lymphoma SPORE

$2,307,384
Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2022 · CA

Multi-component HIV Vaccines Using Engineered Envelopes

$2,306,242
Novartis Vaccines And Diagnostics, Inc. · P01 · FY2003 · AI

Center for Cancer Immunology and Immunotherapy (CCII)

$2,305,905
Jun Yan · University Of Louisville · P20 · FY2023 · GM

HPV Serology

$2,305,845
Lynn Briscoe · Leidos Biomedical Research, Inc. · N01 · FY2025 · CA

NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT

$2,305,737
David Montefiori · Duke University · N01 · FY2018 · AI

Center for Experimental Infectious Disease Research

$2,305,000
Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2010 · RR

Flow Cytometry Core

$2,304,842
Stephen Perfetto · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI

Systems Epigenomics of Persistent Bloodstream Infection

$2,304,639
Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2023 · AI

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities

$2,303,802
S. Mark Tompkins · University Of Georgia · N01 · FY2024 · AI

Brain Tumor Clinical and Clinical Research Program

$2,303,576
Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2016 · CA

Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina

$2,303,568
Rachel R. Caspi · National Eye Institute · ZIA · FY2015 · EY

NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D

$2,303,260
David C Montefiori · Duke University · N01 · FY2016 · AI

Transformed Probiotic Bacteria for Treatment of Chronic Diseases

$2,302,500
Sean Stephen Davies · Vanderbilt University · DP2 · FY2007 · OD